VCU Parkinson's and Movement Disorders Center
Richmond, Virginia, 23230, United States
NCT Number: NCT01646333
This randomized, controlled trial (RCT) evaluates the benefits of memory and problem solving training compared to supportive therapy in individuals with Parkinson's Disease with Mild Cognitive Impairment (MCI) and their support persons. Participants will be randomly assigned to receive memory and problem solving training or supportive therapy for 2-months. A 6-month follow up evaluation will establish if benefits remain over time. Impact of these therapies on thinking abilities, physical health, and patient and support person ratings of thinking skills, mood and quality of life will be evaluated. The memory and problem solving training is hypothesized to result in greater improvements and/or stability of function on neuropsychological tests of attention, working memory, learning, and memory skills compared to the supportive therapy condition. Both conditions are hypothesized to result in improved mood and quality of life ratings.
Results from this study will determine whether memory and problem solving therapies and supportive therapy are easily used by and beneficial for individuals with Parkinson's Disease and Mild Cognitive Impairment. If positive benefit is observed, information from this study will be used to further optimize these therapies for larger trials designed to evaluate the value of the therapies for individuals with Parkinson's Disease and their support persons.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Richmond, Virginia, 23230, United States
The memory and problem solving training consists of a day calendar manual and note taking system and problem solving techniques. The supportive therapy offers patients and support persons the opportunity to discuss and reflect upon both Parkinson's Disease and non-Parkinson's Disease related problems.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8 weekly 1 hour sessions of memory compensation and problem-solving strategies
8 weekly 1 hour sessions of non-directive supportive therapy.
Time frame: Change from Baseline in California Verbal Learning Test-II Long Delay Free Recall Scaled Score at 10 weeks
Change in California Verbal Learning Test-II Long Delay Free Recall Scaled Score from Baseline and 10 weeks
Time frame: Change from Baseline in Linear Analog Scale Assessment Overall Well Being Raw Score at 10 weeks
Change in Linear Analog Scale Assessment Overall Well Being Raw Score from Baseline and 10 weeks
Time frame: Change from Baseline in California Verbal Learning Test-II Long Delay Free Recall Scaled Score at 6 months
Change in California Verbal Learning Test-II Long Delay Free Recall Scaled Score from Baseline and 6 months
Time frame: Change from Baseline in Linear Analog Scale Assessment Overall Well Being Raw Score at 6 months
Change in Linear Analog Scale Assessment Overall Well Being Raw Score from Baseline and 6 months
Virginia Commonwealth University
Other
A Randomized Controlled Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03836963
Basal Ganglia Diseases, Brain Diseases
Hines, Illinois, United States
View Trial DetailsNCT02048605
Basal Ganglia Diseases, Brain Diseases
Basel, Switzerland
View Trial DetailsNCT03243214
Basal Ganglia Diseases, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT01519271
Basal Ganglia Diseases, Brain Diseases
Philadelphia, Pennsylvania, United States
View Trial Details